RAPISCAN sol inj 400 mcg/5ml flac 5 ml
7680661370013
CH-66137
C01EB21
14.03.0.
1 / 3
google
Details
- Product number
- 6613701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- regadenosonum 400 µg, dinatrii phosphas, natrii dihydrogenophosphas, propylenglycolum 750 mg, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 19 mg.
Articles (1)
Rapiscan 400 µg/ 5 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
750.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
19.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 114.60
Specialties list
Yes
Generic
No
SL addition date:
01/02/2018
Authorization holder
GE Healthcare AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 66137
- Drug name
- Rapiscan, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- C01EB21
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/07/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 14.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RAPISCAN sol inj 400 mcg/5ml flac 5 ml
- Description (DE)
- RAPISCAN Inj Lös 400 mcg/5ml Durchstf 5 ml
- Market launch
- 28/07/2017
- Narcotic (BTM)
- No